Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Colony-Stimulating Factors × 1 year × Clear all

Sponsor

Conditions

Neuroblastoma 7 Ganglioneuroblastoma 4 Triple Negative Breast Neoplasms 3 Lung Neoplasms 3 Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Resectable Esophageal Cancer 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Locally Advanced Pancreatic Adenocarcinoma 1 Leukemia, Plasma Cell 1 Gliosarcoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinosarcoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Merkel Cell 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Adenoma, Islet Cell 1

Interventions

Cyclophosphamide 28 fludarabine 20 Whole-Body Irradiation 19 fludarabine phosphate 18 asciminib 18 Mycophenolic Acid 17 nilotinib 14 Tacrolimus 14 Imatinib Mesylate 12 Melphalan 11 Dasatinib 9 ponatinib 8 bosutinib 8 Thiotepa 8 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 Mesna 6 Granulocyte Colony-Stimulating Factor 6 Filgrastim 5 venetoclax 4 olverembatinib 4 blinatumomab 4 Stem Cell Transplantation 4 Sirolimus 4 ruxolitinib 3 Rituximab 3 Hematopoietic Stem Cell Transplantation 3 Cyclosporine 3 Bone Marrow Transplantation 3 Azacitidine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡